Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and Drug Administration (FDA) has approved ProlivtmRx, ...
SOPHiA GENETICS , a global leader in AI-driven precision medicine, today provided preliminary unaudited financial results for the fourth quarter and full year 2025, initiated its financial outlook for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback